NEWTOWN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), today announced the filing of its U.S. Food and Drug Administration (FDA) 510(k) submission for the ...

Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device Designation All statistical analyses for the Functional Gait Assessment ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a medical device company with a market capitalization of $592.1 million and experiencing significant stock volatility according to ...

NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), with a market capitalization of $535.6 million, announced Monday it has changed its corporate name to Solana Company while maintaining ...

Helius Medical Technologies, Inc. (NASDAQ: HSDT), today announced the filing of its U.S. Food and Drug Administration (FDA) 510 (k) submission for the PoNS (Portable Neuromodulation Stimulator) device ...

Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device Designation NEWTOWN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Helius Medical ...

OneStep's fall risk assessment and prevention capabilities will be merged with DarioHealth's chronic condition management ...